Antibiotic sensitivity in periodontally pathogenic bacteria isolated from patients with purulent inflammatory disorders of the periodontal tissues

Autor: Voronkina, I. A., Dyachenko, V. F., Maryuschenko, A.M., Serdechna, E. S., Biryukova, S. V.
Jazyk: ukrajinština
Rok vydání: 2022
Předmět:
ISSN: 2072-2354
DOI: 10.5281/zenodo.6350386
Popis: The treatment of purulent inflammatory diseases in the periodontal tissues (PIDP) is one of the pertinent problems of modern dentistry. Qualitative and quantitative changes in the normal microflora of the oral cavity and activation of the periodontogenic microflora are considered to be some of the main etiological factors of periodontal inflammation. This includes Aggregatibacter actinomycetemcomitans (according to the old nomenclature - Actinobacillus actinomycetemcomitans), Tannerella forsythia (Bacteroides forsythus), Porphyromonas gingivalis, Prevotella intermedia, Wollinella recta (Campylobacter rectus), Fusobacterium nucleatum, Treponema denticola, as well as Parvimonas micra (Peptostreptococcus micros). Both cultivation and identification of the anaerobic microorganisms are considerably labor consuming. In most cases, in the regular laboratory practice, the determination of sensitivity of anaerobic microorganisms to antibacterial agents is not carried out. Therefore, antibacterial therapy is prescribed empirically without considering the general knowledge of anaerobic organisms��� sensitivity to antibiotics. This promotes the appearance of antibiotic resistant strains among microorganisms. As efficacy of antimicrobial therapy remains the main problem in PIDP treatment, we have carried out the study of sensitivity of isolated periodontally pathogenic agents to antibacterial preparations. There were 245 patients studied in total, older than 20 years of age, diagnosed with acute and chronic periodontal diseases, hypertrophic pulpitis, granulating periodontitis, periodontopathy, and local periodontitis with a fistula. The clinical material was collected from gingival pockets adhering to aseptic rules before the start of antibiotic therapy. Determination of antibiotic sensitivity was carried out for the bacteria Porphyromonas spp., Prevotella spp. and Fusobacterium. Sensitivity of the isolated periodontally pathogenic microorganisms��� strains to antibacterial agents was determined according to the recommendations of the Institute of Clinical Laboratory Standards (CLS��). During the study of sensitivity of Porphyromonas spp. to metronidazole it was determined that all clinical isolates were sensitive to that antibacterial agent. Agents of the carbapenem group were also effective, including meropenem, imipenem and ertapenem (100 % sensitive strains). There were 84,6% strains sensitive to clindamycin, benzylpenicillin, ampicillin, amoxicillin, piperacillin. High activity was observed for amoxiclav ��� 100% sensitive strains. Relatively low quantity of strains has demonstrated sensitivity to tetracycline, doxycycline and levomycetin ��� 23% sensitive isolates. As for Prevotella spp., all strains were similarly sensitive to the carbapenem activity. Most of the bacteria have exhibited sensitivity to metronidazole (88,2%) and clindamycin (76,5 % sensitive strains). More than a half of Prevotella spp. strains were sensitive to amoxiclav and piperacillin (58,8 %). The least number of sensitive strains were observed for benzylpenicillin, ampicillin and amoxicillin - ��� 29,4 %. There were 4 isolates among Fusobacterium strains that were sensitive to metronidazole and carbapenems. Lately, sensitivity of anaerobic bacteria to antimicrobial agents has decreased considerably that is confirmed by multiple data in literature, therefor empirical prescription of antibiotics can have little efficacy. Anaerobic bacteria in PIDP are usually isolated in forms of various associations with aerobic microorganisms that considerably complicates antimicrobial therapy, and the selected agents must be equally effective towards all isolated pathogens, therefore search, development, and improvement of approaches and methods of PIDP treatment remain still pertinent today.
{"references":["1.\tMaliy D. Yu., Antonenko Yu. Epidemiology of periodontal disease: vikovy aspect. Ukrainian youth journal of science and medicine. 2013. 4. 41-43.","2.\tEke P .I., Thornton-Evans G., Dye B. A., Genco R. Advances in Surveillance of Periodontitis: The Centers for Disease Control and Prevention Periodontal Disease Surveillance Project. J Periodontol. 2012. 83(11). 1337-42. doi: 10.1902/jop.2012.110676","3.\tEke P. I., Page P. C., Wei L., Thornton-Evans G. at al. Update of the Case Definitions for Population- Based Surveillance of Periodontitis. J Periodontol. 2012. 83(12). 1449-54. doi: 10.1902/jop.2012.110664.","4.\tBaker J. L., Bor B., Agnello M., Shi W. at al. Ecology of the oral microbiome: beyond bacteria. Trends Microbiol. 2017.25(5). 362– 374. doi: 10.1016/j.tim.2016.12.012","5.\tDewhirst F. E., Chen T., Izard J., Paster B. J. at al. The human oral microbiome. J Bacteriol. 2010. 192(19). 5002- 17. doi: 10.1128/JB.00542-10.","6.\tSinev I. I., Nesterov A. M., Sadykov M. I., Khaikin M. B. Modern view on integrated treatment of patients with chronic localized periodontitis of medium severity (a literature review). Aspirantskiy Vestnik Povolzhiya. 2020. 20(1-2). 108-121. doi: 10.17816/2072-2354.2020.20.1.108-121","7.\tRibeiro A. A., Azcarate-Peril M. A., Cadenas M. B., Butz N. at al. The oral bacterial microbiome of occlusal surfaces in children and its association with diet and caries. PLoS One. 2017. 12(7).e0180621. doi: 10.1371/journal.pone.0180621.","8.\tTsarev V. N., Nikolaeva E. N., Ippolitov E. V. Periodontophatogenic bacteria of the main factors of emergence and development of periodontitis. Zh. Mikrobiol. (Moscow). 2017. 5. 101-112. https://doi.org/10.36233/0372-9311-2017-5-101-112.","9.\tBrook I., Wexler H. M., & Goldstein E. J. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clinical microbiology reviews. 2013. 26(3). 526–546. https://doi.org/10.1128/CMR.00086-12","10.\tWexler H. M. Bacteroides - the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 2007. 20. 593–621. doi: 10.1128 / CMR.00008-07","11.\tCitron D. M., Goldstein E. J., Merriam C. V., Lipsky B. A. at al. Bacteriology of moderate- to- severe diabetic foot infections and in vitro activity of antimicrobial agents. J. Clin. Microbiol. 2007. 45.2819– 2828. doi: 10.1128/JCM.00551-07","12.\tGoldstein E. J., Citron D. M., Goldman P. J., Goldman R. J. National survey of anaerobic culture and susceptibility methods: III. Anaerobe. 2008.14. 68–72. doi: 10.1016/j.anaerobe.2008.01.001","13.\tSherwood J. E., Fraser S., Citron D. M., Wexler H. at al. Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe. 2011. 17. 152–155. doi: 10.1016/j.anaerobe.2011.02.007","14.\tSnydman D. R., Jacobus N. V., McDermott L. A., Golan Y. at al. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006- 2009. Anaerobe. 2011. 17. 147– 151. doi: 10.1016/j.anaerobe.2011.05.014","15.\tBrook I. Treatment of anaerobic infection. Expert Rev. Anti Infect. Ther. 2007. 5(6). 991-1006. doi: 10.1586/14787210.5.6.991.","Citron D., Gerardo S., Claros M. et al. Frequency of Isolation of Porphyromonas Species from Infected Dog and Cat Bite Wounds in Humans and Their Characterization by Biochemical Tests and Arbitrarily Primed-Polymerase Chain Reaction Fingerprinting. Clin Infect Dis. 1996. 23. 1:S78-82. doi: 10.1093/clinids/23.supplement_1.s78.","17.\tMatsumoto T., Micamo H., Chapter 1-2. Anaerobic infection (General): epidemiology of anaerobic infections. J Infect Chemother. 2011. 17 1:4-12. doi: 10.1007/s10156-010-0169-y.","18.\tMartande S. S., Pradeep A. R., Singh S. P., Kumari M. at al. Clinical and microbiological effects of systemic azithromycin in adjunct to nonsurgical periodontal therapy in treatment of Aggregatibacter actinomycetemcomitans associated periodontitis: a randomized placebo-controlled clinical trial. J Investig Clin Dent. 2016. 7(1)72-80. doi: 10.1111/jicd.12115","19.\tMorales A., Gandolfo A., Bravo J., Carvajal P. at al. Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo- controlled trial with 9-month follow- up. J Appl Oral Sci. 2018. 18. 26:e20170075. doi: 10.1590/1678-7757-2017-0075.","20.\tGraziani, F., Karapetsa, D., Alonso, B., & Herrera D. Nonsurgical and surgical treatment of periodontitis: how many options for one disease? Periodontology 2000. 2017. 75(1). 152– 188. https://doi.org/10.1111/prd.12201","21.\tEUCAST: European Committee on Antimicrobial Susceptibility Testing breakpoint tables for interpretation of MICs and zone diameters. Version 10.0, 2020. http://www.eucast.org","22.\t CLSI. M100-S22: performance standards for antimicrobial susceptibility testing; twenty-second informational supplement— M100S22E.pdf. http: // www.antimicrobianos.com.ar/ATB/wpcontent/uploads/2012/11/M100S22E.pdf","23.\tLapach S. M., Chubenko A. V., Babich P. N. Statistical methods in biomedical research using Excel. Kiev: \"MORION\", 2001 408 p.","24.\tGlantz S. Biomedical statistics. Transl. from English Moscow: Practice, 1998.459 p.","25.\tAlauzet C., Lozniewski A., Marchandin H. Metronidazole resistance and nim genes in anaerobes: A review. Anaerobe. 2019. 55:40- 53. doi: 10.1016/j.anaerobe.2018.10.004","26.\tKatsandri A., Avlamis A., Pantazatou A., Houhoula D. P. Dissemination of nim-class genes, encoding nitroimidazole resistance, among different species of Gram-negative anaerobic bacteria isolated in Athens, Greece. The Journal of antimicrobial chemotherapy. 2006. 58(3). 705– 706. https://doi.org/10.1093/jac/dkl285","27.\tSood A., Ray P., & Angrup A. Phenotypic and genotypic antimicrobial resistance in clinical anaerobic isolates from India. JAC-antimicrobial resistance. 2021. 3(2). dlab044. https://doi.org/10.1093/jacamr/dlab044","28.\tHellinger W. C., & Brewer N. S. Carbapenems and monobactams: imipenem, meropenem, and aztreonam. Mayo Clinic proceedings. 1999. 74(4). 420–434. https://doi.org/10.4065/74.4.420","29.\tAldridge K. E., Ashcraft D., Cambre K., Pierson C. L. at al. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrobial agents and chemotherapy. 2001. 45(4) 1238–1243. https://doi.org/10.1128/AAC.45.4.1238-1243.2001 .","30.\tNagy E. Multi-drug resistance among anaerobes. Twenty seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria. 2017. Abstract SY0814.","31.\tWexler H. M. Susceptibility testing of anaerobic bacteria: myth, magic, or method? Clinical microbiology reviews. 1991. 4(4). 470– 484. https://doi.org/10.1128/CMR.4.4.470","32.\tAldridg, K. E., Ashcraft D., Cambre K., Pierson, C. L. at al. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrobial agents and chemotherapy. 2001. 45(4). 1238– 1243. https://doi.org/10.1128/AAC.45.4.1238-1243.2001,","33.\tTan T. Y., Ng L. S., Kwan L. L., Rao S. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital. Anaerobe. 2017. 43. 69– 74. https://doi.org/10.1016/j.anaerobe.2016.11.009"]}
Databáze: OpenAIRE
Externí odkaz: